The purpose of this study is to define better the role and understand the mechanisms and consequences of aberrant Jak/STAT signaling in the pathogenesis of cancer by evaluating human T-cell lymphomas. The accumulated experimental evidence indicates that the Jak1/Jak3/STAT3/STAT5 signaling complex associated with the common g chain (gc) shared by several receptors stimulated by cytokines which are critical for activation and maturation of normal T cells: IL-2, -4, -7, -9, -15, and -21, plays a central role in the pathogenesis of a large subset of T-cell lymphomas. Epigenetic silencing of the gene coding for the SHP-1 tyrosine phosphatase, a negative regulator of the cell signaling, contributes to the aberrant, persistent activation of the gc-related Jak/STAT pathways. To accomplish goals of the study we will examine: ? 1. mechanism and functional role of Jak1 and Jak3 activation in the malignant T-cell transformation. We will focus on the putative role of IL-15 and IL-21 in and the relative contribution of Jak1 and Jak3 to the T-cell lymphomagenesis in vitro and of Jak3 in vivo. ? 2. role of STATS, STAT5a and STAT5b in the T-cell transformation by evaluating their relative contributions to the lymphomagenesis. We will focus on the impact of the three STATs on the T-cell lymphoma cell function and gene expression to identify potential effector proteins directly responsible for the malignant cell phenotype. In addition, we will identify the target genes of the STAT3-induced epigenetic gene silencing. ? 3. role of STAT3 in and the mechanisms of the epigenetic silencing of the SHP-1 gene. We will focus on the role of STAT3 and members of the DNA methyltransferase (DNMT) and methyl CpG-binding (MBD) protein families in the DNA methylation of the SHP-1 gene promoter. ? This study should result in a better understanding of the pathogenesis of at least some subtypes of T-cell lymphoma. Furthermore, it may lead to novel therapy(ies) for the lymphoma based on selective inhibition of these elements of the gc-associated Jak/STAT signal transduction pathway that are preferentially utilized and/or abberantly regulated in malignant T cells. Because constant activation of STAT3 and, to lesser degree, of STAT5 has been documented in a large spectrum of malignancies, results of this study may impact on understanding pathogenesis and, ultimately, on treatment of various type of cancer. ? ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA089194-07
Application #
7290974
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Howcroft, Thomas K
Project Start
2001-03-01
Project End
2011-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
7
Fiscal Year
2007
Total Cost
$249,891
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lauenborg, Britt; Christensen, Louise; Ralfkiaer, Ulrik et al. (2015) Malignant T cells express lymphotoxin ? and drive endothelial activation in cutaneous T cell lymphoma. Oncotarget 6:15235-49
Bagdonaite, Ieva; Wandall, Hans H; Litvinov, Ivan V et al. (2015) Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients. Oncotarget 6:14374-84
Willerslev-Olsen, Andreas; Litvinov, Ivan V; Fredholm, Simon M et al. (2014) IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle 13:1306-12
Zhang, Qian; Wang, Hong Yi; Wei, Fang et al. (2014) Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner. J Immunol 192:2913-9
Ralfkiaer, Ulrik; Lindahl, Lise M; Lindal, Lise et al. (2014) MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res 34:7207-17
Fredholm, Simon; Gjerdrum, Lise Mette R; Willerslev-Olsen, Andreas et al. (2014) STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides. Anticancer Res 34:5277-86
Lee, Seung-Cheol; Marzec, Michal; Liu, Xiaobin et al. (2013) Decreased lactate concentration and glycolytic enzyme expression reflect inhibition of mTOR signal transduction pathway in B-cell lymphoma. NMR Biomed 26:106-14
Willerslev-Olsen, Andreas; Krejsgaard, Thorbjørn; Lindahl, Lise M et al. (2013) Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel) 5:1402-21
Zhang, Qian; Wei, Fang; Wang, Hong Yi et al. (2013) The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes. Am J Pathol 183:1971-80
Marzec, Michal; Halasa, Krzysztof; Liu, Xiaobin et al. (2013) Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming. J Immunol 191:6200-7

Showing the most recent 10 out of 56 publications